Esther12
Senior Member (Voting Rights)
The greatest concern is whether they allow other researchers like Carolyn Wilshire, Jonathan Edwards, Ron Davis, Jose Montoya, Ian Lipkin, etc. to access the data. Most of those researchers would be quite concerned about the data in this collaboration. That, though, is a different question to whether they release the data to citizen scientists, which is less important, I think. If possible it's better for properly trained researchers familiar with the research community to lead the way. (You'd find that, although we can think citizen scientists are great, very few in the research community take them seriously.)
The problem with PACE was different, which was that they weren't releasing the data to anyone at all. That's a different problem. The great success of Allem Mathees was getting them to release the data in the first place, not the fact that he allowed citizen scientists to access the data.
That doesn't address the concern I raised.
They were sharing PACE data with those researchers they chose to share it with. This allows them to present the impression of independent scrutiny without risking having their results picked apart by people who knew what they were talking about. The preference for 'bona fide' researchers is taken straight out of the PACE playbook. This is from White in 2013:
"I prefer the Medical Research Council’s current
policy on access to research data. The council
considers release only to bona fide researchers,
who work for bona fide research organisations,
and who sign up to the same standards of
respecting the confidentiality of the data as did
the original researchers.3"
http://www.bmj.com/bmj/section-pdf/187912?path=/bmj/346/7910/Letters.full.pdf
We all saw what that led to.
It wasn't 'properly trained researchers' who led the way with PACE, because the people with the best understanding of the issues were patients. This is repeatedly acknowledged by the researchers who went on to be critical of the trial and the way results were spun.
You seem to continue to have faith in systems that have let patients down.
That came from activism and influencing researchers to do the right thing, not our scientific skills. And that's irrelevant now, because we've got lots of researchers that can represent us.
Your first sentence is just wrong, and the second sentence seems to wrongly assume that there are now lots of researchers in the CFS field who have lots of time to dig into and pick apart the flawed research of others. Is that really what you're assuming?
If patients do want to have input on research, they need to make sure they hold themselves to the same scientific standards that they hold others to, that they don't fall into personally attacking people, or that they don't agree with particular arguments solely for the fact it supports their position. Those are the standards that the scientific community tries (and fails, very often, I know) to hold themselves to, and patients ought to try to hold themselves to those standards too.
There's nothing unscientific about 'personally attacking' those who have behaved badly (assuming that you mean through arguments about the individual's failings, rather than physical violence or something). Andrew Wakefield was personally attacked for being a quack, and there's nothing unscientific about that. It is important that when individuals behave badly they are called out on that. It is in the interest of Establishment figures to promote the view that there's something rather uncivil about wanting to hold authority figures accountable for when they harm others, but that's just BS.
In terms of what is tactically best, it's probably wise to be relatively quiet on calls for accountability and justice at the moment, but that's not because there's anything wrong or 'unscientific' about them, it's just that so many of the people in positions of authority that we need to get on-side live their life according to the warped values of the Establishment.
Also, I'd just given this example of attempts to present legitimate criticism of PACE as "unscientific and sometimes personal attacks". When pointing out methodological problems with research is dismissed as a 'personal attack', we should all support personal attacks.
This dispute between the various protagonists recently surfaced with the PACE trial published in the Lancet [2], which provided evidence for effectiveness of elements of cognitive-behavioural therapy (CBT) and graded exercise therapy (GET) for patients with CFS. This publication triggered unscientific and sometimes personal attacks on the researchers in both the scientific literature [3–10] and via the Internet [11].
- 2 White PD, Goldsmith KA, Johnson AL et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 2011; 377: 823–36.
- 3 Feehan SM. The PACE trial in chronic fatigue syndrome. Lancet 2011; 377: 1831–2.
- 4 Giakoumakis J. The PACE trial in chronic fatigue syndrome. Lancet 2011; 377: 1831; author reply 4–5.
- 5 Kewley AJ. The PACE trial in chronic fatigue syndrome. Lancet 2011; 377: 1832; author reply 4–5.
- 6 Kindlon T. The PACE trial in chronic fatigue syndrome. Lancet 2011; 377: 1833; author reply 4–5.
- 7 Mitchell JT Jr. The PACE trial in chronic fatigue syndrome. Lancet 2011; 377: 1831; author reply 4–5.
- 8 Shinohara M. The PACE trial in chronic fatigue syndrome. Lancet 2011; 377: 1833–4; author reply 4–5.
- 9 Stouten B, Goudsmit EM, Riley N. The PACE trial in chronic fatigue syndrome. Lancet 2011; 377: 1832–3; author reply 4–5.
- 10 Vlaeyen JW, Karsdorp P, Gatzounis R, Ranson S, Schrooten M. The PACE trial in chronic fatigue syndrome. Lancet 2011; 377: 1834; author reply -5.
- 11 Prins JB, van der Meer JWM, Bleijenberg G. Chronic fatigue syndrome. Lancet 2006; 367: 346–55.
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2796.2011.02468.x/full